3-Amino-2,2-dimethylpropanamide | CAS:324763-51-1

We serve 3-Amino-2,2-dimethylpropanamide CAS:324763-51-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Amino-2,2-dimethylpropanamide

Chemical Name: 3-Amino-2,2-dimethylpropanamide
CAS.NO:324763-51-1
Synonyms:
3-amino-2,2-dimethylpropanamide

Molecular Formula:C5H12N2O
Molecular Weight:116.16200

Physical and Chemical Properties:
Density: 1.004
Boiling point: 271ºCat 760 mmHg
Melting point: 74-75ºC
Flash point: 117ºC
Refractive index: 1.47

Specification:
Appearance:white  powder
Purity:≥99%
Heavy metal: ≤10ppm

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Aliskiren CAS:173334-57-1
Intermediates of Aliskiren hemifumarate CAS:173334-58-2



Contact us for information like 3-Amino-2,2-dimethylpropanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Amino-2,2-dimethylpropanamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Amino-2,2-dimethylpropanamide Use and application,3-Amino-2,2-dimethylpropanamide technical grade,usp/ep/jp grade.


Related News: At a national conference on TCM last October, Xi urged experts and officials to carry on and innovate the fine elements in TCM and underlined efforts to promote it internationally, Xinhua reported at the time.1,2-Dibromoethane manufacturer All of China’s provinces and territories have now been touched by the outbreak.4-Bromophenylboronic acid supplier The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.1-fluoro-4-(trifluoromethoxy)benzene vendor The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.